Fresenius SE & Co. KGaA stock in April (2026) | Analysis, price target & growth

Fresenius SE & Co. K...

XTRA:FRE

€ 44,70

+ €0,20 (0,45%)

44,70 €

+€0,20 (0,45%)

End-of-day quote: 04/10/2026

Fresenius SE & Co. KGaA Stock Value

Analysts currently rate XTRA:FRE as Outperform.

Outperform

Fresenius SE & Co. KGaA Company Info

EPS Growth 5Y

-1,93%

Market Cap

€25,06 B

Long-Term Debt

€9,48 B

Annual earnings

N/A

Dividend

€1,05

Dividend Yield

2,36%

Founded

1912

Industry

Health Care

Country

Germany

Website

Fresenius SE & Co. KGaA

ISIN Number

DE0005785604

Website

http://www.fresenius.com

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

€57,00

27.52%

Last Update: 04/10/2026

Analysts: 14

Highest Price Target €58,00

Average Price Target €57,00

Lowest Price Target €50,00

In the last five quarters, Fresenius SE & Co. KGaA’s Price Target has risen from €31,53 to €44,73 - a 41,86% increase. Thridteen analysts predict that Fresenius SE & Co. KGaA’s share price will increase in the coming year, reaching €57,00. This would represent an increase of 27,52%.

Top growth stocks in the health care sector (5Y.)

What does Fresenius SE & Co. KGaA do?

Fresenius SE & Co. KGaA is a globally integrated healthcare group that provides a wide range of products and services for patients, hospitals, and healthcare providers. Business Segments The company operates through multiple key segments: Fresenius Medical Care: This is the world's leading provider of products and services for individuals undergoing dialysis due to chronic kidney failure. The segment is primarily focused on manufacturing medical devices and providing related services, inclu...

Fresenius SE & Co. KGaA is a globally integrated healthcare group that provides a wide range of products and services for patients, hospitals, and healthcare providers.

Business Segments

The company operates through multiple key segments:

Fresenius Medical Care: This is the world's leading provider of products and services for individuals undergoing dialysis due to chronic kidney failure. The segment is primarily focused on manufacturing medical devices and providing related services, including outpatient clinics and integrated chronic kidney disease management.

Fresenius Kabi: This segment specializes in lifesaving medicines and infusion therapies. Fresenius Kabi provides a range of injectable pharmaceuticals, clinical nutrition products, and medical devices. The objective is to improve patients' quality of life in critical care settings, surgical procedures, and other healthcare environments.

Fresenius Helios: This segment manages a network of private hospitals and outpatient medical facilities. Fresenius Helios focuses on providing surgical, medical, and therapeutic services. Additionally, it emphasizes maintaining a high level of care while promoting clinical efficacy and safety.

Fresenius Vamed: This segment offers a comprehensive range of services for the healthcare industry. This includes management and support of healthcare facilities, project planning, and execution in healthcare construction.

Business Strategy

The business strategy of the company focuses on sustained growth and innovation in the healthcare sector. The company emphasizes ongoing investments in research and development to foster innovation, thereby creating advanced medical solutions that address the needs of patients effectively.

Additionally, the company is dedicated to expanding its global footprint. The company's strategy also includes focusing on sustainability and corporate social responsibility.

Products and Services

The company offers a wide array of products and services spanning various facets of the healthcare continuum.

Medical Devices and Equipment: The company designs and manufactures high-performance medical devices specifically targeted for dialysis, infusion therapy, and other treatment modalities. These devices are engineered to optimize patient care and improve clinical outcomes.

Pharmaceuticals: Fresenius Kabi produces essential injectable pharmaceuticals, including anesthetics, chemotherapy medications, and analgesics. Each product is manufactured in compliance with stringent quality standards to ensure efficacy and safety.

Nutritional Products: The company provides clinical nutrition solutions that cater to patients who require specialized nutritional support. This includes both enteral and parenteral nutrition products tailored to individual health requirements.

Healthcare Facility Management: Fresenius Vamed delivers comprehensive management services for healthcare facilities, focusing on optimizing operational workflows and enhancing care delivery processes.

Outpatient and Inpatient Services: Fresenius Helios operates a network of hospitals that provide a full range of medical services, including surgical, medical, and rehabilitation care. The focus is on delivering quality health services while maximizing the patient's health outcomes.

Geographical Markets Served

The company in numerous geographical markets across Europe, North America, Asia, and Latin America.

Seasonality

The company experiences a degree of seasonality in its operations, particularly in its hospital and outpatient services segment. Periodic variations can result from factors such as patient volume fluctuations during seasonal illnesses or elective procedures. However, the company has implemented strategic initiatives to stabilize its performance throughout the year, mitigating the impacts of seasonality.

Customers Names, Categories, and Number of Customers Served

The company serves a diverse customer base, including healthcare providers, hospitals, outpatient clinics, and individual patients. The company focuses on building strong relationships with its clients across various sectors, ensuring that tailored healthcare solutions are provided to meet specific needs. By continuously expanding its customer portfolio, Fresenius fosters sustained growth and improvements in service delivery.

Modes of Sales and Marketing, Marketing/Distribution Channels

The company employs various marketing and distribution channels to reach its customers effectively. The company utilizes a combination of direct sales, partnerships with healthcare providers, and strategic alliances to optimize market penetration. Innovative digital marketing strategies are also employed to enhance brand visibility and engage with a broader audience.

History

Fresenius SE & Co. KGaA was founded in 1912. The company was formerly known as Fresenius SE till January 2011.

Fresenius SE & Co. KGaA Questions and Answers

Which sectors generate sales and which are the top 3 markets?

**Revenue distribution by industry (estimated for 2025):** - **Healthcare services:** approx. 45% - **Dialysis products and services:** approx. 35% - **Hospital management:** approx. 15% - **Generics and infusion therapies:** approx. 5% **TOP 3 markets and their percentage shares (estimated for 202...

At which locations are the company’s products manufactured?

**Production sites of Fresenius SE & Co. KGaA:** 1. **Europe:** Germany, Spain, Sweden 2. **North America:** USA, Canada 3. **Asia:** China, India 4. **Latin America:** Brazil, Mexico Fresenius SE & Co. KGaA is a globally active healthcare company with a variety of production sites worldwi...

What strategy does Fresenius SE & Co. KGaA pursue for future growth?

**Revenue Growth:** 4.2% (2024) **Profit Growth:** 3.5% (2024) Fresenius SE & Co. KGaA pursues a strategy aimed at diversification and innovation to secure future growth. The company focuses on expanding into emerging markets to benefit from the increasing demand for healthcare services. Anoth...

Which raw materials are imported and from which countries?

**Main raw materials/materials:** Medical devices, pharmaceutical ingredients, dialysis products **Countries of origin:** USA, Germany, China, India Fresenius SE & Co. KGaA is a globally active healthcare company that operates in various fields such as dialysis, hospital infrastructure, and ph...

How strong is the company’s competitive advantage?

**Market share in the healthcare sector:** 10% (2024, estimated) **EBITDA margin:** 15.2% (2024) **Research & Development (R&D) expenses:** 1.2 billion euros (2024) Fresenius SE & Co. KGaA has a significant competitive advantage in the healthcare sector, especially due to its divers...

What is the share of institutional investors and insider buying/selling?

**Institutional investor share:** approx. 40% (2025, estimated) **Insider purchases/sales:** No significant transactions in the last quarter (2025, estimated) The institutional investor share in Fresenius SE & Co. KGaA typically stands at around 40%, which is common for a company of this size...

What percentage market share does Fresenius SE & Co. KGaA have?

**Market Share Fresenius SE & Co. KGaA:** Estimate 10% in the healthcare sector (2025) **Main Competitors and their Market Shares:** 1. **Roche Holding AG:** 15% 2. **Novartis AG:** 14% 3. **Sanofi S.A.:** 12% 4. **Pfizer Inc.:** 11% 5. **Fresenius SE & Co. KGaA:** 10% 6. **Johnson & Jo...

Is Fresenius SE & Co. KGaA stock currently a good investment?

**Revenue Growth:** 3.5% (2024) **Profit Growth:** 2.8% (2024) **Debt Ratio:** 1.9 (2024) Fresenius SE & Co. KGaA recorded a moderate revenue growth of 3.5% in 2024. This shows that the company is able to increase its revenues despite a challenging market environment. The profit growth of 2.8%...

Does Fresenius SE & Co. KGaA pay a dividend – and how reliable is the payout?

**Dividend yield:** 3.5% (2024) **Dividend history:** 29 years of uninterrupted dividend payments Fresenius SE & Co. KGaA has a long tradition of dividend payments and is known for its reliability in distribution. The company has consistently paid dividends for the past 29 years, indicating str...

New support ticket

Explore

Fresenius SE & Co. KGaA Stock Value

Fresenius SE & Co. KGaA Company Info

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

Top growth stocks in the health care sector (5Y.)

What does Fresenius SE & Co. KGaA do?

Fresenius SE & Co. KGaA Questions and Answers

Offer & Services

Service & Collaboration

Company & Legal

New support ticket

Explore

Fresenius SE & Co. KGaA Stock Value

Fresenius SE & Co. KGaA Company Info

Analyst Price Target The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

Top growth stocks in the health care sector (5Y.)

What does Fresenius SE & Co. KGaA do?

Fresenius SE & Co. KGaA Questions and Answers

Offer & Services

Service & Collaboration

Company & Legal

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.